Detalhe da pesquisa
1.
Modulation of Premetastatic Niche by the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Localized High-Risk Prostate Cancer Followed by Radical Prostatectomy: A Phase II Randomized Trial.
Oncologist
; 23(12): 1413-e151, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30575560
2.
Prospective Evaluation of Bone Metabolic Markers as Surrogate Markers of Response to Radium-223 Therapy in Metastatic Castration-resistant Prostate Cancer.
Clin Cancer Res
; 26(9): 2104-2110, 2020 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31937614
3.
Randomized phase II trial of sipuleucel-T immunotherapy preceded by sensitizing radiation therapy and sipuleucel-T alone in patients with metastatic castrate resistant prostate cancer.
Cancer Treat Res Commun
; 19: 100116, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30682445